Sees FY26 revenue $3.22B-$3.28B, consensus $3.24B.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WST:
- West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.83
- West Pharmaceutical price target lowered to $295 from $365 at Jefferies
- WST Earnings this Week: How Will it Perform?
- West Pharmaceutical price target lowered to $320 from $390 at Evercore ISI
- West Pharmaceutical Services: GLP-1 Dependency, Emerging Oral-Formulation Risks, and Insufficient Diversification Justify Hold Rating